DARIN HAMLIN: Open Payments
NPI 1669821047 · PARSONS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 42 payments from 7 companies in 2025. Trend: 2023 $342 · 2024 $550 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $213 |
| AstraZeneca Pharmaceuticals LP | 10 | $186 |
| Novo Nordisk Inc | 5 | $82 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: AIRSUPRA, VRAYLAR, QULIPTA, BEXSERO, CAPLYTA, UBRELVY, FARXIGA, Rybelsus.
Industry payments across KS — which companies pay providers there.
